ETF Foundry
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
momentum factor · long-only model fund

Foundry 12-Month Momentum Industry-Neutral Factor ETF

ETF Foundry Research (hypothetical) · rebalanced monthly

FMORHYPOTHETICAL MODEL
Since ’99
+360%
Expense Ratio
0.35%
placeholder
Holdings
296
cap-weighted
Inception
May 2020
placeholder
Full Sharpe
0.35
Ann. Return (LS)
8.7%
Ann. Volatility
25.1%
Max Drawdown
-63.7%
Test Sharpe ’19–26
0.54
Test FF5 α (ann.)
18.6%
vs Fama-French 5
Test FF5 α t-stat
2.11
significant (|t| ≥ 2)
Monthly turnover
28%
of the long leg, per rebalance
Cumulative return (LS)
360%
over 331 months
This fund holds the long leg only
Long leg Sharpe
0.63
what this fund holds
Long leg ann. return
15.9%
buyable, long-only
Long-short Sharpe
0.35
requires shorting
Bottom bucket ann. return
7.2%
the basket shorted

Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.

Hypothetical growth of $1 — long-short backtest

Gross of the placeholder expense ratio and trading costs · not investor results

331 months

Holdings

Every constituent of the long leg — sort, search or filter by sector

296 of 296 · 100.0% of book
TickerCompanySectorMarket capWeight
1MU
MICRON TECHNOLOGY INCTechnology$958.80B
14.88%
2AMD
ADVANCED MICRO DEVICES INCTechnology$808.39B
12.55%
3INTC
INTEL CORPTechnology$477.67B
7.42%
4AMAT
APPLIED MATERIALS INCTechnology$420.53B
6.53%
5CAT
CATERPILLAR INCIndustrials$405.49B
6.29%
6LRCX
LAM RESEARCH CORPTechnology$391.80B
6.08%
7KLAC
KLA CORPTechnology$277.91B
4.31%
8DELL
DELL TECHNOLOGIES INCTechnology$256.87B
3.99%
9SNDK
SANDISK CORPTechnology$200.63B
3.11%
10STX
SEAGATE TECHNOLOGY HOLDINGS PLCTechnology$176.62B
2.74%
11MRVL
MARVELL TECHNOLOGY INCTechnology$165.06B
2.56%
12WDC
WESTERN DIGITAL CORPTechnology$164.49B
2.55%
13GLW
CORNING INCTechnology$133.06B
2.07%
14BE
BLOOM ENERGY CORPIndustrials$61.14B
0.95%
15HPE
HEWLETT PACKARD ENTERPRISE COTechnology$60.67B
0.94%
16FIX
COMFORT SYSTEMS USA INCIndustrials$58.93B
0.91%
17LITE
LUMENTUM HOLDINGS INCTechnology$57.01B
0.89%
18COHR
COHERENT CORPTechnology$54.31B
0.84%
19CIEN
CIENA CORPTechnology$53.00B
0.82%
20ALAB
ASTERA LABS INCTechnology$52.04B
0.81%
21TER
TERADYNE INCTechnology$50.46B
0.78%
22RVMD
REVOLUTION MEDICINES INCHealthcare$39.58B
0.61%
23RKLB
ROCKET LAB CORPIndustrials$39.14B
0.61%
24CNC
CENTENE CORPHealthcare$32.81B
0.51%
25CRS
CARPENTER TECHNOLOGY CORPIndustrials$27.71B
0.43%
26ECHO
ECHO GLOBAL LOGISTICS INCIndustrials$26.66B
0.41%
27ATI
ATI INCIndustrials$25.41B
0.39%
28ROIV
ROIVANT SCIENCES LTDHealthcare$24.82B
0.39%
29MRNA
MODERNA INCHealthcare$24.53B
0.38%
30MKSI
MKS INCTechnology$21.93B
0.34%
31ENTG
ENTEGRIS INCTechnology$21.16B
0.33%
32GH
GUARDANT HEALTH INCHealthcare$20.67B
0.32%
33STRL
STERLING INFRASTRUCTURE INCIndustrials$19.59B
0.30%
34SNX
TD SYNNEX CORPTechnology$19.40B
0.30%
35AMKR
AMKOR TECHNOLOGY INCTechnology$15.60B
0.24%
36SITM
SITIME CORPTechnology$14.65B
0.23%
37ALB
ALBEMARLE CORPBasic Materials$14.24B
0.22%
38ONTO
ONTO INNOVATION INCTechnology$13.92B
0.22%
39TTMI
TTM TECHNOLOGIES INCTechnology$13.71B
0.21%
40BTSG
BRIGHTSPRING HEALTH SERVICES INCHealthcare$13.71B
0.21%
41MOD
MODINE MANUFACTURING COConsumer Cyclical$12.11B
0.19%
42COKE
COCA-COLA CONSOLIDATED INCConsumer Defensive$12.03B
0.19%
43AXSM
AXSOME THERAPEUTICS INCHealthcare$11.84B
0.18%
44VICR
VICOR CORPTechnology$10.83B
0.17%
45ARWR
ARROWHEAD PHARMACEUTICALS INCHealthcare$10.47B
0.16%
46KRYS
KRYSTAL BIOTECH INCHealthcare$10.46B
0.16%
47HUT
HUT 8 CORPFinancial Services$10.30B
0.16%
48GSAT
GLOBALSTAR INCCommunication Services$10.20B
0.16%
49APGE
APOGEE THERAPEUTICS INCHealthcare$10.10B
0.16%
50DAR
DARLING INGREDIENTS INCConsumer Defensive$10.03B
0.16%
51VSAT
VIASAT INCTechnology$9.76B
0.15%
52HL
HECLA MINING COBasic Materials$9.61B
0.15%
53MSGS
MADISON SQUARE GARDEN SPORTS CORPCommunication Services$9.56B
0.15%
54KYMR
KYMERA THERAPEUTICS INCHealthcare$9.52B
0.15%
55ESI
ELEMENT SOLUTIONS INCBasic Materials$9.11B
0.14%
56WULF
TERAWULF INCFinancial Services$9.00B
0.14%
57VIAV
VIAVI SOLUTIONS INCTechnology$8.93B
0.14%
58OSCR
OSCAR HEALTH INCHealthcare$8.77B
0.14%
59PRAX
PRAXIS PRECISION MEDICINES INCHealthcare$8.77B
0.14%
60SYRE
SPYRE THERAPEUTICS INCHealthcare$8.70B
0.14%
61POWL
POWELL INDUSTRIES INCIndustrials$8.48B
0.13%
62IMVT
IMMUNOVANT INCHealthcare$8.27B
0.13%
63FORM
FORMFACTOR INCTechnology$8.23B
0.13%
64AAOI
APPLIED OPTOELECTRONICS INCTechnology$8.22B
0.13%
65IBRX
IMMUNITYBIO INCHealthcare$8.04B
0.12%
66PL
PLANET LABS PBCIndustrials$8.01B
0.12%
67AGX
ARGAN INCIndustrials$7.73B
0.12%
68PACS
PACS GROUP INCHealthcare$7.30B
0.11%
69ENS
ENERSYSIndustrials$7.18B
0.11%
70LQDA
LIQUIDIA CORPHealthcare$7.11B
0.11%
71COGT
COGENT BIOSCIENCES INCHealthcare$6.68B
0.10%
72VSXY
VICTORIA'S SECRET & COConsumer Cyclical$6.47B
0.10%
73MXL
MAXLINEAR INCTechnology$6.43B
0.10%
74CGON
CG ONCOLOGY INCHealthcare$6.34B
0.10%
75M
MACY'S INCConsumer Cyclical$6.23B
0.10%
76MYRG
MYR GROUP INCIndustrials$6.10B
0.09%
77LGND
LIGAND PHARMACEUTICALS INCHealthcare$6.08B
0.09%
78ERAS
ERASCA INCHealthcare$5.96B
0.09%
79GTX
GARRETT MOTION INCConsumer Cyclical$5.95B
0.09%
80OUT
OUTFRONT MEDIA INCReal Estate$5.85B
0.09%
81TWST
TWIST BIOSCIENCE CORPHealthcare$5.84B
0.09%
82KGS
KODIAK GAS SERVICES INCEnergy$5.79B
0.09%
83ENVA
ENOVA INTERNATIONAL INCFinancial Services$5.79B
0.09%
84DNTH
DIANTHUS THERAPEUTICS INCHealthcare$5.77B
0.09%
85PRM
PERIMETER SOLUTIONS INCBasic Materials$5.61B
0.09%
86ORKA
ORUKA THERAPEUTICS INCHealthcare$5.59B
0.09%
87ACMR
ACM RESEARCH INCTechnology$5.56B
0.09%
88TXG
10X GENOMICS INCHealthcare$5.55B
0.09%
89SSRM
SSR MINING INCBasic Materials$5.31B
0.08%
90TVTX
TRAVERE THERAPEUTICS INCHealthcare$5.27B
0.08%
91VSH
VISHAY INTERTECHNOLOGY INCTechnology$5.15B
0.08%
92SPHR
SPHERE ENTERTAINMENT COCommunication Services$5.10B
0.08%
93MTRN
MATERION CORPBasic Materials$5.10B
0.08%
94KLIC
KULICKE & SOFFA INDUSTRIES INCTechnology$5.09B
0.08%
95DFTX
DEFINIUM THERAPEUTICS INCHealthcare$4.83B
0.07%
96VCYT
VERACYTE INCHealthcare$4.72B
0.07%
97LFST
LIFESTANCE HEALTH GROUP INCHealthcare$4.49B
0.07%
98LIVN
LIVANOVA PLCHealthcare$4.43B
0.07%
99SEI
SOLARIS ENERGY INFRASTRUCTURE INCEnergy$4.43B
0.07%
100CELC
CELCUITY INCHealthcare$4.31B
0.07%
101INSW
INTERNATIONAL SEAWAYS INCEnergy$4.29B
0.07%
102EWTX
EDGEWISE THERAPEUTICS INCHealthcare$4.28B
0.07%
103ACLS
AXCELIS TECHNOLOGIES INCTechnology$4.19B
0.07%
104COCO
VITA COCO COMPANY INCConsumer Defensive$4.18B
0.06%
105UCTT
ULTRA CLEAN HOLDINGS INCTechnology$4.14B
0.06%
106TNGX
TANGO THERAPEUTICS INCHealthcare$4.13B
0.06%
107LION
LIONSGATE STUDIOS CORPCommunication Services$4.03B
0.06%
108LASR
NLIGHT INCTechnology$3.91B
0.06%
109DK
DELEK US HOLDINGS INCEnergy$3.88B
0.06%
110RLAY
RELAY THERAPEUTICS INCHealthcare$3.81B
0.06%
111CLMT
CALUMET INCEnergy$3.73B
0.06%
112ALMS
ALUMIS INCHealthcare$3.65B
0.06%
113NHC
NATIONAL HEALTHCARE CORPHealthcare$3.56B
0.06%
114MSGE
MADISON SQUARE GARDEN ENTERTAINMENT CORPConsumer Cyclical$3.56B
0.06%
115CALY
CALLAWAY GOLF COConsumer Cyclical$3.48B
0.05%
116GPCR
STRUCTURE THERAPEUTICS INCHealthcare$3.45B
0.05%
117RCUS
ARCUS BIOSCIENCES INCHealthcare$3.44B
0.05%
118ELVN
ENLIVEN THERAPEUTICS INCHealthcare$3.24B
0.05%
119ONDS
ONDAS INCTechnology$3.23B
0.05%
120VECO
VEECO INSTRUMENTS INCTechnology$3.19B
0.05%
121KN
KNOWLES CORPTechnology$3.01B
0.05%
122AXTI
AXT INCTechnology$3.00B
0.05%
123MBX
MBX BIOSCIENCES INCHealthcare$2.99B
0.05%
124ICHR
ICHOR HOLDINGS LTDTechnology$2.88B
0.04%
125ADEA
ADEIA INCTechnology$2.80B
0.04%
126VISN
VISTANCE NETWORKS INCTechnology$2.74B
0.04%
127ESTA
ESTABLISHMENT LABS HOLDINGS INCHealthcare$2.72B
0.04%
128TRVI
TREVI THERAPEUTICS INCHealthcare$2.71B
0.04%
129ANDE
ANDERSONS INCConsumer Defensive$2.70B
0.04%
130HLIO
HELIOS TECHNOLOGIES INCIndustrials$2.68B
0.04%
131UNIT
UNITI GROUP INCReal Estate$2.68B
0.04%
132KOD
KODIAK SCIENCES INCHealthcare$2.67B
0.04%
133FLNC
FLUENCE ENERGY INCUtilities$2.59B
0.04%
134KALU
KAISER ALUMINUM CORPBasic Materials$2.58B
0.04%
135GRDN
GUARDIAN PHARMACY SERVICES INCHealthcare$2.57B
0.04%
136AEHR
AEHR TEST SYSTEMSTechnology$2.55B
0.04%
137DCO
DUCOMMUN INCIndustrials$2.54B
0.04%
138QURE
UNIQURE NVHealthcare$2.54B
0.04%
139SLS
SELLAS LIFE SCIENCES GROUP INCHealthcare$2.45B
0.04%
140COHU
COHU INCTechnology$2.41B
0.04%
141ATRO
ASTRONICS CORPIndustrials$2.41B
0.04%
142ROG
ROGERS CORPTechnology$2.36B
0.04%
143OUST
OUSTER INCTechnology$2.36B
0.04%
144NKTR
NEKTAR THERAPEUTICSHealthcare$2.31B
0.04%
145SION
SIONNA THERAPEUTICS INCHealthcare$2.23B
0.03%
146DHC
DIVERSIFIED HEALTHCARE TRUSTReal Estate$2.22B
0.03%
147VSTS
VESTIS CORPIndustrials$2.18B
0.03%
148AGL
AGILON HEALTH INCHealthcare$2.17B
0.03%
149PEB
PEBBLEBROOK HOTEL TRUSTReal Estate$2.16B
0.03%
150AXGN
AXOGEN INCHealthcare$2.12B
0.03%
151GLUE
MONTE ROSA THERAPEUTICS INCHealthcare$2.07B
0.03%
152CDNA
CAREDX INCHealthcare$2.05B
0.03%
153RAPP
RAPPORT THERAPEUTICS INCHealthcare$2.04B
0.03%
154NUVB
NUVATION BIO INCHealthcare$2.03B
0.03%
155PLSE
PULSE BIOSCIENCES INCHealthcare$1.98B
0.03%
156EZPW
EZCORP INCFinancial Services$1.97B
0.03%
157ECPG
ENCORE CAPITAL GROUP INCFinancial Services$1.96B
0.03%
158ATEX
ANTERIX INCCommunication Services$1.96B
0.03%
159DMRA
DAMORA THERAPEUTICS INCHealthcare$1.94B
0.03%
160TYRA
TYRA BIOSCIENCES INCHealthcare$1.91B
0.03%
161NGL
NGL ENERGY PARTNERS LPEnergy$1.89B
0.03%
162MRVI
MARAVAI LIFESCIENCES HOLDINGS INCHealthcare$1.87B
0.03%
163ALGT
ALLEGIANT TRAVEL COIndustrials$1.86B
0.03%
164BCAX
BICARA THERAPEUTICS INCHealthcare$1.82B
0.03%
165LIND
LINDBLAD EXPEDITIONS HOLDINGS INCIndustrials$1.81B
0.03%
166STOK
STOKE THERAPEUTICS INCHealthcare$1.81B
0.03%
167HYMC
HYCROFT MINING HOLDING CORPBasic Materials$1.74B
0.03%
168BFLY
BUTTERFLY NETWORK INCHealthcare$1.73B
0.03%
169TSHA
TAYSHA GENE THERAPIES INCHealthcare$1.71B
0.03%
170CBL
CBL & ASSOCIATES PROPERTIES INCReal Estate$1.71B
0.03%
171ANAB
ANAPTYSBIO INCHealthcare$1.69B
0.03%
172FTRE
FORTREA HOLDINGS INCHealthcare$1.68B
0.03%
173CMPS
COMPASS PATHWAYS PLCHealthcare$1.67B
0.03%
174TH
TARGET HOSPITALITY CORPIndustrials$1.64B
0.03%
175TE
T1 ENERGY INCIndustrials$1.63B
0.03%
176PSNL
PERSONALIS INCHealthcare$1.61B
0.03%
177PLPC
PREFORMED LINE PRODUCTS COIndustrials$1.60B
0.02%
178PUMP
PROPETRO HOLDING CORPEnergy$1.59B
0.02%
179INNV
INNOVAGE HOLDING CORPHealthcare$1.56B
0.02%
180SKYT
SKYWATER TECHNOLOGY INCTechnology$1.54B
0.02%
181ATLC
ATLANTICUS HOLDINGS CORPFinancial Services$1.52B
0.02%
182SEPN
SEPTERNA INCHealthcare$1.51B
0.02%
183ALNT
ALLIENT INCTechnology$1.49B
0.02%
184AIP
ARTERIS INCTechnology$1.43B
0.02%
185RMIX
SUNCRETE INCBasic Materials$1.40B
0.02%
186VPG
VISHAY PRECISION GROUP INCTechnology$1.38B
0.02%
187LINC
LINCOLN EDUCATIONAL SERVICES CORPConsumer Defensive$1.36B
0.02%
188REAL
THEREALREAL INCConsumer Cyclical$1.35B
0.02%
189BW
BABCOCK & WILCOX ENTERPRISES INCIndustrials$1.35B
0.02%
190FBYD
FALCON'S BEYOND GLOBAL INCIndustrials$1.35B
0.02%
191NWPX
NWPX INFRASTRUCTURE INCIndustrials$1.33B
0.02%
192PBT
PERMIAN BASIN ROYALTY TRUSTEnergy$1.32B
0.02%
193UFCS
UNITED FIRE GROUP INCFinancial Services$1.31B
0.02%
194INBX
INHIBRX BIOSCIENCES INCHealthcare$1.28B
0.02%
195TTI
TETRA TECHNOLOGIES INCEnergy$1.25B
0.02%
196CRVS
CORVUS PHARMACEUTICALS INCHealthcare$1.25B
0.02%
197FCEL
FUELCELL ENERGY INCIndustrials$1.25B
0.02%
198TDAY
USA TODAY CO INCConsumer Cyclical$1.25B
0.02%
199NBR
NABORS INDUSTRIES LTDEnergy$1.24B
0.02%
200DRTS
ALPHA TAU MEDICAL LTDHealthcare$1.19B
0.02%
201AVNS
AVANOS MEDICAL INCHealthcare$1.17B
0.02%
202MYE
MYERS INDUSTRIES INCConsumer Cyclical$1.17B
0.02%
203ETON
ETON PHARMACEUTICALS INCHealthcare$1.16B
0.02%
204SVRA
SAVARA INCHealthcare$1.13B
0.02%
205CAPR
CAPRICOR THERAPEUTICS INCHealthcare$1.13B
0.02%
206RHLD
RESOLUTE HOLDINGS MANAGEMENT INCIndustrials$1.10B
0.02%
207GOLD
GOLDCOM INCFinancial Services$1.09B
0.02%
208CGEM
CULLINAN THERAPEUTICS INCHealthcare$1.09B
0.02%
209JBIO
JADE BIOSCIENCES INCHealthcare$1.03B
0.02%
210AVTX
AVALO THERAPEUTICS INCHealthcare$1.02B
0.02%
211BIOA
BIOAGE LABS INCHealthcare$1.01B
0.02%
212APPS
DIGITAL TURBINE INCTechnology$1.01B
0.02%
213OLMA
OLEMA PHARMACEUTICALS INCHealthcare$1.00B
0.02%
214ABX
ABACUS GLOBAL MANAGEMENT INCFinancial Services$994M
0.02%
215EVC
ENTRAVISION COMMUNICATIONS CORPCommunication Services$984M
0.02%
216ANRO
ALTO NEUROSCIENCE INCHealthcare$967M
0.02%
217LWLG
LIGHTWAVE LOGIC INCBasic Materials$960M
0.01%
218ANNX
ANNEXON INCHealthcare$950M
0.01%
219TROX
TRONOX HOLDINGS PLCBasic Materials$932M
0.01%
220APEI
AMERICAN PUBLIC EDUCATION INCConsumer Defensive$930M
0.01%
221ARKO
ARKO CORPConsumer Cyclical$893M
0.01%
222MOV
MOVADO GROUP INCConsumer Cyclical$859M
0.01%
223AVR
ANTERIS TECHNOLOGIES GLOBAL CORPHealthcare$823M
0.01%
224ACRS
ACLARIS THERAPEUTICS INCHealthcare$793M
0.01%
225DSGN
DESIGN THERAPEUTICS INCHealthcare$785M
0.01%
226CLYM
CLIMB BIO INCHealthcare$727M
0.01%
227OMER
OMEROS CORPHealthcare$701M
0.01%
228MAMA
MAMA'S CREATIONS INCConsumer Defensive$700M
0.01%
229PKE
PARK AEROSPACE CORPIndustrials$677M
0.01%
230PSTL
POSTAL REALTY TRUST INCReal Estate$664M
0.01%
231LPTH
LIGHTPATH TECHNOLOGIES INCTechnology$657M
0.01%
232FEIM
FREQUENCY ELECTRONICS INCTechnology$650M
0.01%
233TCMD
TACTILE SYSTEMS TECHNOLOGY INCHealthcare$648M
0.01%
234ACHV
ACHIEVE LIFE SCIENCES INCHealthcare$644M
0.01%
235CLDT
CHATHAM LODGING TRUSTReal Estate$624M
0.01%
236FET
FORUM ENERGY TECHNOLOGIES INCEnergy$593M
0.01%
237PACK
RANPAK HOLDINGS CORPConsumer Cyclical$583M
0.01%
238STTK
SHATTUCK LABS INCHealthcare$577M
0.01%
239FDMT
4D MOLECULAR THERAPEUTICS INCHealthcare$575M
0.01%
240IMMX
IMMIX BIOPHARMA INCHealthcare$558M
0.01%
241RYAM
RAYONIER ADVANCED MATERIALS INCBasic Materials$555M
0.01%
242RLMD
RELMADA THERAPEUTICS INCHealthcare$550M
0.01%
243NPCE
NEUROPACE INCHealthcare$548M
0.01%
244ELA
ENVELA CORPConsumer Cyclical$547M
0.01%
245PKOH
PARK OHIO HOLDINGS CORPIndustrials$544M
0.01%
246XMAX
XMAX INCConsumer Cyclical$541M
0.01%
247CTNM
CONTINEUM THERAPEUTICS INCHealthcare$532M
0.01%
248ORN
ORION GROUP HOLDINGS INCIndustrials$518M
0.01%
249ZURA
ZURA BIO LTDHealthcare$518M
0.01%
250NVCT
NUVECTIS PHARMA INCHealthcare$508M
0.01%
251KYTX
KYVERNA THERAPEUTICS INCHealthcare$453M
0.01%
252ALTO
ALTO INGREDIENTS INCBasic Materials$453M
0.01%
253STRZ
STARZ ENTERTAINMENT CORPCommunication Services$450M
0.01%
254BETR
BETTER HOME & FINANCE HOLDING COFinancial Services$442M
0.01%
255FSTR
FOSTER L B COIndustrials$439M
0.01%
256PBYI
PUMA BIOTECHNOLOGY INCHealthcare$434M
0.01%
257FLXS
FLEXSTEEL INDUSTRIES INCConsumer Cyclical$391M
0.01%
258STRO
SUTRO BIOPHARMA INCHealthcare$391M
0.01%
259ZNTL
ZENTALIS PHARMACEUTICALS INCHealthcare$364M
0.01%
260ELMD
ELECTROMED INCHealthcare$349M
0.01%
261MRAM
EVERSPIN TECHNOLOGIES INCTechnology$341M
0.01%
262CV
CAPSOVISION INCHealthcare$335M
0.01%
263TWIN
TWIN DISC INCIndustrials$326M
0.01%
264VELO
VELO3D INCTechnology$316M
0.00%
265OSS
ONE STOP SYSTEMS INCTechnology$313M
0.00%
266OPTX
SYNTEC OPTICS HOLDINGS INCTechnology$302M
0.00%
267DBI
DESIGNER BRANDS INCConsumer Cyclical$290M
0.00%
268QTTB
Q32 BIO INCHealthcare$255M
0.00%
269SRZN
SURROZEN INCHealthcare$255M
0.00%
270RELL
RICHARDSON ELECTRONICS LTDTechnology$250M
0.00%
271ASYS
AMTECH SYSTEMS INCTechnology$242M
0.00%
272ARTV
ARTIVA BIOTHERAPEUTICS INCHealthcare$241M
0.00%
273KPTI
KARYOPHARM THERAPEUTICS INCHealthcare$216M
0.00%
274BDSX
BIODESIX INCHealthcare$204M
0.00%
275FOCL
FOCAL INCHealthcare$204M
0.00%
276INTT
INTEST CORPTechnology$169M
0.00%
277KORE
KORE GROUP HOLDINGS INCCommunication Services$163M
0.00%
278AP
AMPCO PITTSBURGH CORPIndustrials$156M
0.00%
279SIF
SIFCO INDUSTRIES INCIndustrials$141M
0.00%
280OCC
OPTICAL CABLE CORPTechnology$130M
0.00%
281VTVT
VTV THERAPEUTICS INCHealthcare$130M
0.00%
282VATE
INNOVATE CORPIndustrials$123M
0.00%
283SPRB
SPRUCE BIOSCIENCES INCHealthcare$120M
0.00%
284WYY
WIDEPOINT CORPTechnology$115M
0.00%
285TRT
TRIO-TECH INTERNATIONALTechnology$103M
0.00%
286CHRN
CHRONOSCALE CORPIndustrials$94M
0.00%
287RLYB
RALLYBIO CORPHealthcare$87M
0.00%
288INTG
INTERGROUP CORPConsumer Cyclical$84M
0.00%
289NRXS
NEURAXIS INCHealthcare$84M
0.00%
290VNCE
VINCE HOLDING CORPConsumer Cyclical$83M
0.00%
291ROLR
HIGH ROLLER TECHNOLOGIES INCConsumer Cyclical$76M
0.00%
292BNAI
BRAND ENGAGEMENT NETWORK INCTechnology$76M
0.00%
293BODI
BEACHBODY COMPANY INCCommunication Services$75M
0.00%
294LONA
LEONABIO INCHealthcare$68M
0.00%
295NDLS
NOODLES & COConsumer Cyclical$66M
0.00%
296EDSA
EDESA BIOTECH INCHealthcare$59M
0.00%

Full long-leg book as of July 2026 · cap-weighted · total market cap $6.44T. Hypothetical model holdings — not a registered fund’s portfolio.

Sector Breakdown

11 sectors
Technology
77.6%
Industrials
11.3%
Healthcare
7.1%
Basic Materials
0.9%
Consumer Cyclical
0.7%
Financial Services
0.5%
Communication Services
0.5%
Consumer Defensive
0.5%
Energy
0.5%
Real Estate
0.2%
Utilities
0.0%

Portfolio Style

Size × value map of the long-leg book

296 classified
Value
Blend
Growth
Large
Mid
Small
<1%2
30%23
63%57
1%18
1%42
2%57
<1%12
<1%26
<1%22

Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 97% toward Large, 83% toward Growth. +2% unclassified (37 missing size/value). Hypothetical holdings — descriptive, not realized P&L.

Tilt over time
Size tilt97% → Large
SmallLarge
Value ↔ growth tilt83% → Growth
ValueGrowth

Capital-weighted centroid of the long leg, December 1998July 2026; the right-hand end is the same value as the box’s dot. 296 names now. Hypothetical holdings — descriptive, not P&L.

Constraint checks

How this book measures against the concentration and liquidity rules — as implemented here

How this book was built

These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.

Passed
4
Failed
1
Not tested
2
Independent checks
7

7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.

2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.

  • The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).

    Required
    <= 25.0%
    Actual
    48.7%
    Margin
    -23.7%
Reported separately — arithmetically implied

Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.

No verdict sits within 1.0pp of its limit.

Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700

Measured on the 2026-07 formation date across 296 holdings (cap-weighted). A different formation date can produce different verdicts.

Derivatives risk (Rule 18f-4)

Whether this long-only book is subject to the VaR tests at all

This assessment describes the long-only book this fund holds — the top bucket only.

Governing rule
Rule 18f-4(c)(4) limited derivatives user exception

This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.

Limited derivatives user exceptionby construction

Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.

Qualifies
Required
<= 10% of net assets
Exposure
0% of net assets
Margin
+10pp

No confidence interval: this follows from portfolio construction, not from an estimate.

Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.

Informational — does not govern

This fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.

Measured
1.5 (95% CI 1.0-2.3)
x reference VaR
Limit
2.00x
<= 2.00x reference VaR
Fund VaR
14.1%
99% / 20d
Reference
9.6%
FF5 market (mkt)

historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months

Same test, three estimators
historical
1.47x
within
parametric
1.58x
within
cornish fisher
1.56x
within

The estimators agree, which is mild evidence the number isn’t an artefact of one method.

Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.

The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.

See the long-short verdict on the factor page →

Since publication

Did the edge survive the paper coming out?

published 1993
Entirely since publication
All 331 months of our record post-date the 1993 paper.
Sharpe 0.358.7% p.a.January 1999July 2026

There is no “before” to compare against — the predictor was already public when our data begins, so every month shown is out-of-sample relative to the original study.

Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.

Consistency across eras

Is this record broadly durable, or one regime?

26 windows
Positive windows
77%
20 of 26 3-year windows made money
Worst window
-0.52
Sharpe, January 2004 – December 2006
January 1999July 2026
Median Sharpe
0.32
Dispersion
0.44
Best window
1.52

3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.

Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.

Returns

Long leg is what this fund holds — long-short is shown for reference

since January 1999
Trailing
PeriodLong legLong-short
1 yearcum.45.2%2.2%
3 yearsp.a.41.4%18.4%
5 yearsp.a.23.9%16.9%
10 yearsp.a.23.1%11.5%
Since inceptionp.a.13.6%5.7%
Calendar years
YearLong legLong-short
20267 mo38.2%12.0%
202511.0%-11.3%
202470.7%57.4%
202336.8%16.2%
2022-16.6%22.3%
2021-0.4%-21.2%
202059.1%50.1%
201922.8%-13.1%
20181.8%24.8%
201731.8%17.6%
20164.4%-22.0%
20152.3%23.8%
201412.9%10.2%
201333.8%-9.6%
201213.5%-6.2%
2011-6.7%7.9%
201026.6%1.2%
200913.7%-44.3%
2008-32.5%41.5%
200729.6%33.7%
20062.7%-15.1%
200514.0%4.7%
20041.9%-9.3%
200355.3%12.9%
2002-16.3%22.8%
2001-17.1%-18.6%
2000-27.0%-24.8%
1999113.3%93.1%

Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.

Fund Facts

Ticker (pseudo)FMOR
IssuerETF Foundry Research (hypothetical)
SeriesHypothetical Model Portfolio Series (not a registered trust)
Expense ratio0.35% (placeholder)
Inception2020-05-11 (placeholder)
Listing exchangeNot listed (hypothetical)
CUSIPNot applicable (hypothetical model portfolio)
RebalanceMonthly
Holdings as ofJuly 2026
Total mkt cap (long leg)$6.44T

Methodology

The Foundry 12-Month Momentum Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a 12-Month Momentum signal and holds the top decile with the highest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.

This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.

Documents (draft — hypothetical)

Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.

Summary Prospectus

Objective, fees, strategy, and key risks.

View →
Prospectus

Full strategy, model methodology, and risks.

View →
Statement of Additional Information

Policies, construction, and governance.

View →
Fact Sheet

One-page snapshot with top holdings.

View →
Daily Holdings

Full current constituent list.

View →

DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.